Evaluating Immunome: Insights From 4 Financial Analysts
In the preceding three months, 4 analysts have released ratings for Immunome (NASDAQ:IMNM), presenting a wide array of…
Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares,…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Rezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday’s after-market session. The company’s market cap stands…
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What’s Driving Markets Thursday?
In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions.
Immunome Announces Proposed $200M Public Offering of Common Stock
Immunome, Inc. ("Immunome") (NASDAQ:IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers InVivo Therapeutics Hldg (NASDAQ:NVIV) stock rose 306.0% to $0.9 during Tuesday’s regular session. The company’s market cap…
Immunome To Acquire Antibody-Related Assets And Materials From Atreca; Under The Terms Of The Asset Purchase Agreement, Immunome Would Pay Atreca A $5.5M Upfront Payment And Up To $7M In Clinical Development Milestones
Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it entered into a definitive asset purchase agreement with
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday.
The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P 500, also rose, gaining, 0.28% to 4,389.22.
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Sigilon Therapeutics (NASDAQ:SGTX) shares rose 506.6% to $23.84 during Thursday’s regular session. Trading volume for this security…